Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.

Within our stratified analysis by type of therapy, for anti-PD1/PD-L1 monotherapy, we observed an OR per SD of 1.25 (95% CI = 0.88−1.78, p = 0.21) for all-grade IMC, while a slightly stronger and nominally significant association was seen for severe IMC (OR per SD = 1.47, 95% CI = 0.96−2.25, p = 0.08).

also in 7,732 other papers